Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma

被引：0
|
作者：
Jin Woo Choi
Jin Wook Chung
Dong Ho Lee
Hyo-Cheol Kim
Saebeom Hur
Myungsu Lee
Hwan Jun Jae
机构：
[1] Seoul National University Hospital,Section of Interventional Radiology, Department of Radiology, Seoul National University College of Medicine
来源：
European Radiology | 2018年 / 28卷
关键词：
Hepatocellular carcinoma; Chemoembolization, therapeutic; Portal hypertension; Computed tomography, X-ray; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2184 / 2193
页数：9
相关论文
共 50 条
  • [1] Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma
    Choi, Jin Woo
    Chung, Jin Wook
    Lee, Dong Ho
    Kim, Hyo-Cheol
    Hur, Saebeom
    Lee, Myungsu
    Jae, Hwan Jun
    EUROPEAN RADIOLOGY, 2018, 28 (05) : 2184 - 2193
  • [2] Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization
    Kim, Nam Hee
    Lee, Taeheon
    Cho, Yong Kyun
    Kim, Byung Ik
    Kim, Hong Joo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (07) : 1397 - 1406
  • [3] Obesity conveys poor outcome in patients with hepatocellular carcinoma treated by transarterial chemoembolization
    Wu, S. E.
    Charles, H. W.
    Park, J. S.
    Goldenberg, A. S.
    Deipolyi, A. R.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2017, 98 (01) : 37 - 42
  • [4] Factors Associated with Transarterial Chemoembolization Outcome for Hepatocellular Carcinoma
    Thuy Tran Ngoc
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 51 - 51
  • [5] Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis
    Abdella H.
    Shaker M.K.
    Montasser I.F.
    Sobhi M.
    Aly H.
    Sayed A.
    Saleh S.
    El Dorry A.
    Indian Journal of Gastroenterology, 2018, 37 (2) : 127 - 132
  • [6] Outcome of supraselective transarterial chemoembolization in patients with hepatocellular carcinoma
    Heinzow, Hauke Sebastian
    Meister, Tobias
    Nass, Dominik
    Koehler, Michael
    Spieker, Tilmann
    Wolters, Heiner
    Domschke, Wolfram
    Domagk, Dirk
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2011, 46 (02) : 201 - 210
  • [7] Predictors of poor outcome for transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC).
    Prins, Petra
    Singh, Bhavana P.
    Armstrong, Samantha Ann
    He, Aiwu Ruth
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] IMPACT OF CLINICALLY EVIDENT PORTAL HYPERTENSION ON RESPONSE TO TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA
    Tchoumak, Irina
    Faitot, Francois
    Besch, Camille
    Moliere, Sebastien
    Veillon, Francis
    Bachellier, Philippe
    Duclos, Bernard
    Serfaty, Lawrence
    Reimund, Jean-Marie
    GASTROENTEROLOGY, 2018, 154 (06) : S1243 - S1243
  • [9] Impact of transarterial chemoembolization on the outcome of hepatocellular carcinoma
    Amer, Mohamed O.
    Richards, Lisa M.
    Barakat, Fatma
    Kono, Yuko
    Rose, Steven
    Hart, Marquis
    Alpert, Elliot
    Hassanein, Tarek
    GASTROENTEROLOGY, 2007, 132 (04) : A202 - A202
  • [10] Inflammatory Markers are Associated with Outcome in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Megan E. McNally
    Antonio Martinez
    Hooman Khabiri
    Gregory Guy
    Anthony J. Michaels
    James Hanje
    Robert Kirkpatrick
    Mark Bloomston
    Carl R. Schmidt
    Annals of Surgical Oncology, 2013, 20 : 923 - 928
12345